Medtronic cash flow statement
In fiscal 2026, Medtronic's operations generated $7.33bn of cash; it spent $1.90bn on capital projects, leaving free cash flow of $5.43bn. It returned $3.64bn in dividends and $1.03bn through buybacks.
Cash flow statement
| Fiscal year | 2013Apr 2013 | 2014Apr 2014 | 2015Apr 2015 | 2016Apr 2016 | 2017Apr 2017 | 2018Apr 2018 | 2019Apr 2019 | 2020Apr 2020 | 2021Apr 2021 | 2022Apr 2022 | 2023Apr 2023 | 2024Apr 2024 | 2025Apr 2025 | 2026Apr 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 4,942 | 4,959 | 4,902 | 5,218 | 6,880 | 4,684 | 7,007 | 7,234 | 6,240 | 7,346 | 6,039 | 6,787 | 7,044 | 7,330 | 8,035 |
| Depreciation and amortisation | 819 | 850 | 1,306 | 2,820 | 2,917 | 2,644 | 2,659 | 2,663 | 2,702 | 2,707 | 2,697 | 2,647 | 2,861 | 2,958 | 2,035 |
| Stock-based pay | 152 | 145 | 439 | 375 | 348 | 344 | 290 | 297 | 344 | 359 | 355 | 393 | 429 | 457 | 497 |
| Capital spending | 457 | 396 | 571 | 1,046 | 1,254 | 1,068 | 1,134 | 1,213 | 1,355 | 1,368 | 1,459 | 1,587 | 1,859 | 1,904 | 1,903 |
| Free cash flow | 4,485 | 4,563 | 4,331 | 4,172 | 5,626 | 3,616 | 5,873 | 6,021 | 4,885 | 5,978 | 4,580 | 5,200 | 5,185 | 5,426 | 6,132 |
| Free cash flow after stock pay | 4,333 | 4,418 | 3,892 | 3,797 | 5,278 | 3,272 | 5,583 | 5,724 | 4,541 | 5,619 | 4,225 | 4,807 | 4,756 | 4,969 | 5,635 |
| Dividends paid | 1,055 | 1,116 | 1,337 | 2,139 | 2,376 | 2,494 | 2,693 | 2,894 | 3,120 | 3,383 | 3,616 | 3,666 | 3,589 | 3,639 | 3,650 |
| Share buybacks | 1,247 | 2,553 | 1,920 | 2,830 | 3,544 | 2,171 | 2,877 | 1,326 | 652 | 2,544 | 645 | 2,138 | 3,235 | 1,035 | 1,179 |
| Shares issued | 267 | 1,307 | 649 | 491 | 428 | 403 | 992 | 662 | 474 | 429 | 308 | 284 | 508 | 516 | 441 |
| Quarter | 2025 Q2Oct 2024 | 2025 Q3Jan 2025 | 2025 Q4Apr 2025 | 2026 Q1Jul 2025 | 2026 Q2Oct 2025 | 2026 Q3Jan 2026 | 2026 Q4Apr 2026 | 2027 Q1Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 958 | 2,572 | 2,528 | 1,088 | 925 | 2,744 | 2,573 | 1,793 |
| Depreciation and amortisation | 262 | 268 | 840 | 748 | 282 | 308 | 716 | 729 |
| Stock-based pay | 159 | 98 | 89 | 86 | 182 | 95 | 95 | 125 |
| Capital spending | 404 | 476 | 459 | 504 | 468 | 444 | 488 | 503 |
| Free cash flow | 554 | 2,096 | 2,069 | 584 | 457 | 2,300 | 2,085 | 1,290 |
| Free cash flow after stock pay | 395 | 1,998 | 1,980 | 498 | 275 | 2,205 | 1,990 | 1,165 |
| Shares issued | 143 | 168 | 108 | 95 | 160 | 164 | 97 | 20 |
Compare with peers
- Abbott Laboratories cash flow
- Stryker Corporation cash flow
- GE HealthCare cash flow
- Boston Scientific cash flow
- Koninklijke Philips NV cash flow
Head to head: ABT vs MDTMDT vs SYKGEHC vs MDT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies